Suntrust Banks’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $875K | Sell |
8,927
-10,928
| -55% | -$1.07M | ﹤0.01% | 778 |
|
2019
Q2 | $2.6M | Sell |
19,855
-1,172
| -6% | -$153K | 0.01% | 508 |
|
2019
Q1 | $2.84M | Buy |
21,027
+3,289
| +19% | +$445K | 0.02% | 461 |
|
2018
Q4 | $1.73M | Sell |
17,738
-2,977
| -14% | -$290K | 0.01% | 556 |
|
2018
Q3 | $2.88M | Buy |
20,715
+1,273
| +7% | +$177K | 0.01% | 446 |
|
2018
Q2 | $2.41M | Sell |
19,442
-565
| -3% | -$70.2K | 0.01% | 484 |
|
2018
Q1 | $2.23M | Buy |
20,007
+4,982
| +33% | +$555K | 0.01% | 494 |
|
2017
Q4 | $1.8M | Sell |
15,025
-14,373
| -49% | -$1.72M | 0.01% | 547 |
|
2017
Q3 | $4.12M | Buy |
29,398
+176
| +0.6% | +$24.7K | 0.02% | 341 |
|
2017
Q2 | $3.56M | Buy |
29,222
+2,389
| +9% | +$291K | 0.02% | 348 |
|
2017
Q1 | $3.25M | Sell |
26,833
-3,129
| -10% | -$379K | 0.02% | 350 |
|
2016
Q4 | $3.67M | Sell |
29,962
-3,125
| -9% | -$382K | 0.02% | 355 |
|
2016
Q3 | $4.05M | Buy |
33,087
+659
| +2% | +$80.7K | 0.03% | 334 |
|
2016
Q2 | $3.79M | Sell |
32,428
-4,322
| -12% | -$504K | 0.02% | 333 |
|
2016
Q1 | $5.12M | Buy |
36,750
+1,096
| +3% | +$153K | 0.03% | 263 |
|
2015
Q4 | $6.8M | Buy |
35,654
+20,240
| +131% | +$3.86M | 0.04% | 229 |
|
2015
Q3 | $2.41M | Sell |
15,414
-1,042
| -6% | -$163K | 0.02% | 376 |
|
2015
Q2 | $2.97M | Sell |
16,456
-1,881
| -10% | -$340K | 0.02% | 344 |
|
2015
Q1 | $3.18M | Sell |
18,337
-40
| -0.2% | -$6.93K | 0.02% | 322 |
|
2014
Q4 | $3.4M | Sell |
18,377
-8,309
| -31% | -$1.54M | 0.02% | 304 |
|
2014
Q3 | $4.42M | Sell |
26,686
-3,161
| -11% | -$524K | 0.03% | 273 |
|
2014
Q2 | $4.66M | Sell |
29,847
-209,385
| -88% | -$32.7M | 0.03% | 277 |
|
2014
Q1 | $36.4M | Sell |
239,232
-106,022
| -31% | -$16.1M | 0.13% | 221 |
|
2013
Q4 | $45.9M | Sell |
345,254
-7,042
| -2% | -$936K | 0.18% | 185 |
|
2013
Q3 | $40.9M | Sell |
352,296
-55,750
| -14% | -$6.48M | 0.16% | 199 |
|
2013
Q2 | $37.6M | Buy |
+408,046
| New | +$37.6M | 0.17% | 189 |
|